Oscar Health (OSCR) Q4 Earnings: Revenue Up 30.6% y/y, EPS Expected -$0.92

Oscar Health (NYSE:OSCR) reports earnings Tuesday before the market opens. Last quarter, the company generated $2.99 billion, up 23.3% year-on-year, but missed revenue expectations by 3.3% and posted an adjusted loss of $0.92 per share. For Q4 2026, analysts expect revenue to rise 30.6% y/y to $3.12 billion, down from 67.1% in the same quarter of 2025. Peers Cigna and Centene posted revenue growth of 10.4% and 21.9%, respectively. With the S&P 500 Health Insurance Providers sector down 3.1% in February 2026 and OSCR down 29.9% over the month, the outlook is weighed by potential trade policy and tax changes. The average analyst price target is $15.78 versus the current share price of $12.38.